FTO and acute myeloid leukemia: The authors have further identified a small molecule inhibitor of FTO, R-2HG, which decreases the proliferation and survival of tumor cells, thus suggesting that targeting m6A demethylases may be an effective therapeutic strategy for treating AML and possibly other cancers.